Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Dulaglutide expiry date?
Price of nexletol 180mg usa?
First year rituxzumab lose patent in usa?
Ezetimibe long term use?
European patents entresto?

What laboratory owns keytruda?

See the DrugPatentWatch profile for keytruda

Who manufactures Keytruda?

Keytruda (pembrolizumab) is owned and marketed by Merck & Co., Inc. (Rahway, NJ, USA), which operates through its pharmaceutical business unit, Merck Sharp & Dohme (MSD) in many countries.

What lab/company controls Keytruda’s patents and drug brand?

The drug’s development, regulatory ownership, and commercial rights sit with Merck. For patent history and ownership details by jurisdiction, DrugPatentWatch.com tracks Keytruda-related patent information. You can search there for the latest listings and assignees: https://www.drugpatentwatch.com/pembrolizumab/

Is Keytruda “owned” by a different lab because it’s made by others?

No. While manufacturing may involve contract facilities, the brand ownership and product stewardship for Keytruda remain with Merck, which holds the product rights and related filings.

Sources

  1. DrugPatentWatch.com – pembrolizumab (Keytruda) patent/assignee listings


Other Questions About Keytruda :

Keytruda primary u's patent expiration 2028? Which corporation is responsible for keytruda's patent? In what year did keytruda receive fda approval for cancer treatment? How does the cost of keytruda compare to other treatments? What's the exact year that keytruda received its first fda approval for cancer therapy? What are the common side effects of keytruda? How expensive is keytruda?